Health Tidings Mergers & AcquisitionsMcKesson to Acquire Precision Medicine Group for $2.25 Billion, Expanding C... McKesson to Acquire Precision Medicine Group for $2.25 Billion, Expanding C... Read Post »
Health TidingsCDSCO Expert Committee Recommends Bioequivalence and Phase III Trial Waiver... CDSCO Expert Committee Recommends Bioequivalence and Phase III Trial Waiver... Read Post »
Health TidingsErasca Granted FDA Fast Track Designation for ERAS-0015 in Metastatic Pancr... Erasca Granted FDA Fast Track Designation for ERAS-0015 in Metastatic Pancr... Read Post »
Health TidingsLEQEMBI IQLIK® (lecanemab-irmb) Autoinjector for Initiation and Maintenanc... LEQEMBI IQLIK® (lecanemab-irmb) Autoinjector for Initiation and Maintenanc... Read Post »
Health TidingsFDA Extends Deramiocel Review to November 2026 as Capricor Refines DMD Indi... FDA Extends Deramiocel Review to November 2026 as Capricor Refines DMD Indi... Read Post »
Health TidingsFDA Accepts United’s NDA for Ralinepag in Pulmonary Arterial Hypertension FDA Accepts United’s NDA for Ralinepag in Pulmonary Arterial Hypertension Read Post »
Health TidingsFDA Accepts Jemperli (Dostarlimab) for Priority Review in dMMR/MSI-H Locall... FDA Accepts Jemperli (Dostarlimab) for Priority Review in dMMR/MSI-H Locall... Read Post »
Health Tidings Mergers & AcquisitionsHanmi Pharm Signs Up to $2.3 Billion Genentech Deal for Obesity Candidate H... Hanmi Pharm Signs Up to $2.3 Billion Genentech Deal for Obesity Candidate H... Read Post »
Health TidingsSenju Advances SJP-0049 Into Phase III Trial in Japan for Allergic Conjunct... Senju Advances SJP-0049 Into Phase III Trial in Japan for Allergic Conjunct... Read Post »
GenericsZydus Secures USFDA Approval for Ascorbic Acid Injection for Scurvy Zydus Secures USFDA Approval for Ascorbic Acid Injection for Scurvy Read Post »
Health Tidings Mergers & AcquisitionsWerewolf Therapeutics and Ambros Therapeutics Merge to Advance Neridronate ... Werewolf Therapeutics and Ambros Therapeutics Merge to Advance Neridronate ... Read Post »
Health TidingsGossamer Secures Up to $250 Million to Advance Seralutinib Toward FDA Revie... Gossamer Secures Up to $250 Million to Advance Seralutinib Toward FDA Revie... Read Post »
Health TidingsMilestone Advances Etripamil into Phase 3 Trial for Acute AFib With Rapid V... Milestone Advances Etripamil into Phase 3 Trial for Acute AFib With Rapid V... Read Post »
Health TidingsNIH Awards $6.5 Million Grant to Advance Phase 3 PP-01 Trial in Cannabis Us... NIH Awards $6.5 Million Grant to Advance Phase 3 PP-01 Trial in Cannabis Us... Read Post »
Health TidingsRein Therapeutics Receives FDA Fast Track Designation for LTI-03 in Idiopat... Rein Therapeutics Receives FDA Fast Track Designation for LTI-03 in Idiopat... Read Post »
Health Tidings Mergers & AcquisitionsChai Discovery and Bristol Myers Squibb Partner to Advance AI-Driven Antibo... Chai Discovery and Bristol Myers Squibb Partner to Advance AI-Driven Antibo... Read Post »
Health TidingsNuvation Bio’s Safusidenib Receives FDA Fast Track Designation in IDH1-Mu... Nuvation Bio’s Safusidenib Receives FDA Fast Track Designation in IDH1-Mu... Read Post »
Health Tidings Mergers & AcquisitionsTolerance Bio Advances Efineptakin Alfa into Phase 2 Development for Thymic... Tolerance Bio Advances Efineptakin Alfa into Phase 2 Development for Thymic... Read Post »
Health TidingsFDA Details Clinical Evidence Supporting ASCENIV Expansion to Children Aged... FDA Details Clinical Evidence Supporting ASCENIV Expansion to Children Aged... Read Post »
GenericsGlenmark Wins U.S. FDA Approval for Fluticasone Propionate Nasal Spray Glenmark Wins U.S. FDA Approval for Fluticasone Propionate Nasal Spray Read Post »
Health TidingsKaliVir Raises $14 Million to Advance VET3-TGI in Phase 1/1b Solid Tumor Tr... KaliVir Raises $14 Million to Advance VET3-TGI in Phase 1/1b Solid Tumor Tr... Read Post »
Health TidingsFDA Accepts Teva’s NDA for Ecopipam with Priority Review for Pediatric To... FDA Accepts Teva’s NDA for Ecopipam with Priority Review for Pediatric To... Read Post »
Health TidingsConsano Bio’s C-1101 Wins FDA Fast Track for Chronic Sciatica Consano Bio’s C-1101 Wins FDA Fast Track for Chronic Sciatica Read Post »
Health Tidings Mergers & AcquisitionsFulcrum-Slate Merger Creates New Platform to Advance Next-Generation Migrai... Fulcrum-Slate Merger Creates New Platform to Advance Next-Generation Migrai... Read Post »
Health TidingsKynexis Advances KYN-5356 Toward Registrational Development in Schizophreni... Kynexis Advances KYN-5356 Toward Registrational Development in Schizophreni... Read Post »
Health Tidings Mergers & AcquisitionsIDEAYA and Genentech Partner to Evaluate IDE892 Plus GDC-7035 in PDAC IDEAYA and Genentech Partner to Evaluate IDE892 Plus GDC-7035 in PDAC Read Post »
Health TidingsAbcuro Raises $66M Series D for Ulviprubart IBM Phase 3 Trial Abcuro Raises $66M Series D for Ulviprubart IBM Phase 3 Trial Read Post »
Health Tidings Mergers & AcquisitionsChugai’s AID351 Anti-Dengue Antibody Licensed to GSK for Clinical Develop... Chugai’s AID351 Anti-Dengue Antibody Licensed to GSK for Clinical Develop... Read Post »
Health Tidings Mergers & AcquisitionsBioMarin to Acquire Alesta Therapeutics for $275 Million Upfront to Advance... BioMarin to Acquire Alesta Therapeutics for $275 Million Upfront to Advance... Read Post »
Health TidingsAVITA Medical Reports PermeaDerm Study Results Showing 70% Lower Treatment ... AVITA Medical Reports PermeaDerm Study Results Showing 70% Lower Treatment ... Read Post »
Health TidingsEvaxion Shifts Cancer Vaccine Focus to Glioblastoma With EVX-05 Following E... Evaxion Shifts Cancer Vaccine Focus to Glioblastoma With EVX-05 Following E... Read Post »
Health Tidings Mergers & AcquisitionsLEO Pharma Agrees to Acquire Dersimelagon, Expanding Late-Stage Rare Dermat... LEO Pharma Agrees to Acquire Dersimelagon, Expanding Late-Stage Rare Dermat... Read Post »
Health TidingsBlossomHill’s BH-30643 Gets FDA Fast Track Designation for EGFR C797S-Pos... BlossomHill’s BH-30643 Gets FDA Fast Track Designation for EGFR C797S-Pos... Read Post »
Health TidingsEli Lilly Joins $30 Million Series A to Advance Leal’s Schizophrenia and ... Eli Lilly Joins $30 Million Series A to Advance Leal’s Schizophrenia and ... Read Post »
GenericsBiocon Receives U.S. FDA Approval for YESINTEK® Single-Dose Prefilled Auto... Biocon Receives U.S. FDA Approval for YESINTEK® Single-Dose Prefilled Auto... Read Post »
Health TidingsFDA Grants Fast Track Designation to PIKTOR Plus Paclitaxel for Biomarker-S... FDA Grants Fast Track Designation to PIKTOR Plus Paclitaxel for Biomarker-S... Read Post »
Health TidingsFate Therapeutics Advances Fixed-Dose FT819 Into Phase 2 Lupus Nephritis Tr... Fate Therapeutics Advances Fixed-Dose FT819 Into Phase 2 Lupus Nephritis Tr... Read Post »
Health TidingsEyePoint Reports Mixed Phase 3 Results for DURAVYU in Wet AMD EyePoint Reports Mixed Phase 3 Results for DURAVYU in Wet AMD Read Post »
Health TidingsGalmed Reports 3–4-Fold Increase in Prostate Cancer Cell Death with Aramc... Galmed Reports 3–4-Fold Increase in Prostate Cancer Cell Death with Aramc... Read Post »
Health TidingsSpevatamig Receives FDA Fast Track Designation for Advanced and Metastatic ... Spevatamig Receives FDA Fast Track Designation for Advanced and Metastatic ... Read Post »
Health TidingsEnhertu Improves Progression-Free Survival in First-Line HER2-Mutant NSCLC ... Enhertu Improves Progression-Free Survival in First-Line HER2-Mutant NSCLC ... Read Post »
Health TidingsMHRA Approves Vimseltinib for Adults with Tenosynovial Giant Cell Tumour MHRA Approves Vimseltinib for Adults with Tenosynovial Giant Cell Tumour Read Post »
Health TidingsAbelZeta Secures IND Clearance for C-CAR039 in Relapsed or Refractory Large... AbelZeta Secures IND Clearance for C-CAR039 in Relapsed or Refractory Large... Read Post »
Health TidingsPfizer and Valneva Advances Lyme Disease Vaccine to EMA Review After Positi... Pfizer and Valneva Advances Lyme Disease Vaccine to EMA Review After Positi... Read Post »
Medical DevicesFDA Clears Galaxy Buds for Adults With Mild to Moderate Hearing Loss FDA Clears Galaxy Buds for Adults With Mild to Moderate Hearing Loss Read Post »
Health TidingsCaribou Reports Mature CAR-T Trials Results for Vispa-cel in LBCL and CB-01... Caribou Reports Mature CAR-T Trials Results for Vispa-cel in LBCL and CB-01... Read Post »
Health TidingsTHPharm Bets on Reverse Drug Development, Linking Drug Effects to New Disea... THPharm Bets on Reverse Drug Development, Linking Drug Effects to New Disea... Read Post »
Health TidingsLilly Escalates Legal Action Against U.S. Sellers of Unapproved Retatrutide Lilly Escalates Legal Action Against U.S. Sellers of Unapproved Retatrutide Read Post »
Health TidingsNatera and Kupando Collaborate on Phase 1 Trial of KUP-101 Using Latitude t... Natera and Kupando Collaborate on Phase 1 Trial of KUP-101 Using Latitude t... Read Post »
Health TidingsSagimet Receives FDA Clearance to Advance Phase 3 Denifanstat Acne Trial Sagimet Receives FDA Clearance to Advance Phase 3 Denifanstat Acne Trial Read Post »
